Results 241 to 250 of about 33,772,144 (297)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Examining the relationships between e-health literacy, cyberchondria, health anxiety, and health perception among foreign university students. [PDF]

BMC Public Health
Aslan H, Koca GŞ.
europepmc   +1 more source

E-Health and M-Health in Obesity Management: A Systematic Review and Meta-Analysis of RCTs. [PDF]

Nutrients
Chiavarini M, Giacchetta I, Rosignoli P, Fabiani R.   +3 more
europepmc   +1 more source

Bridging the digital divide: A snapshot on e-health literacy among medical students in Tamil Nadu, South India. [PDF]

J Educ Health Promot
Kulothungan K, Mohandas NV, Rizvana AMS, George N, Anand VV, Swetha R, Ayesha ST, Udhayakumari K, Vallikkannu S, Venkatesan R.   +9 more
europepmc   +1 more source

An Analysis of Switching Behavior from Traditional Hospital Visit to E-Health Consultation. [PDF]

Healthcare (Basel)
Sriram S, Mohandoss H, Sunder NP, Amirthalingam B.   +3 more
europepmc   +1 more source

A ZKP-based anonymous biometric authentication scheme for the E-health systems. [PDF]

PLoS One
Mao X, Zhou X, Zhao X, Chen Y.
europepmc   +1 more source

Retraction: Universal school-based e-health interventions for wellbeing, anxiety and depression: A systematic review and meta-analysis. [PDF]

Digit Health
europepmc   +1 more source